Partnering

Partnering

 

Lyramid is interested to out-license its developments to pharmaceutical companies that have the commitment and the required therapeutic area experience to effectively progress our products to marketed patient treatments.

Lyramid is also interested in collaborating with research and commercial partners to further develop midkine diagnostics, based on Lyramid’s proprietary midkine antibodies.

 

For more information, please contact us

Contact Us